FHTX vs GEN · rev $22.6M vs P/E 17, rev $5.00B
Foghorn Therapeutics Inc (FHTX) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
FHTX currently screens at market cap $237.8M. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the FHTX and GEN stock pages for the full models.
Not investment advice.